Transplantation and oncogenic risk: the role of viruses
|
|
- Sybil Payne
- 6 years ago
- Views:
Transcription
1 Transplantation and oncogenic risk: the role of viruses VIM 2014, Katoomba Associate Professor Angela Webster
2 What can transplantation help us understand about infection and cancer? Context: transplantation overview and the nature of immunosuppression Epidemiological data on cancer risk How epi relates to cancer causality Similarities to other immunosuppressed states Cessation of immunosuppression
3 Why is transplantation useful for understanding cancer? The context: Transplantation overview and the nature of immunosuppression
4 How many transplants are there?
5 How many transplants are there? Kidney transplants by year, absolute numbers
6 2012 activity
7 Transplant recipients require prolonged iatrogenic immunosuppression Combination of agents Calcineurin inhibitor/ anti metabolite/ steroid Tacrolimus/ MMF/ Prednisolone Common for all solid organ transplants Intensity may vary By organ Over time from transplant Withdrawn when organ fails (kidneys)
8 Rationale for multiple agents: protection from immunological injury with minimal toxicity
9 What do we know about cancer in the transplanted population? Epidemiological data on cancer risk
10 Much based on health data linkage Australia is in a fortunate position 1. Longstanding, population-based, high quality Death registries Cancer registries Disease registries, including organ transplant recipients and donors 2. Other administrative databases 3. Data linkage expertise and infrastructure Benefits now recognised, further national capacity building underway (PHRN)
11 Why health data linkage? Robust (cohort) data High sensitivity and specificity of linkages Internationally accepted Level of evidence second to RCTs Patient outcomes beyond those known to an institution or state/territory health dept Minimises bias Outcomes relative to matched general population Standardised classification systems Community acceptance linkage by independent 3 rd parties. privacy preserving protocols linkage process increasingly automated
12 Attributing timing of Cancer Diagnosis relative to transplant career not entirely straightforward CKD DIALYSIS TRANSPLANT Reality for some with kidney disease is less clear cut Potential for cycling between dialysis and transplantation Other solid organ transplant recipients have no other life sustaining options past transplantation
13 Cancer occurs in 80% of kidney transplanted patients by 30 years 100% 80% 60% Any Cancer Skin Non Skin Age-Matched Gen. Pop Australia and NZ 100% 80% 60% 40% 40% 20% 20% 0% % Years Post Transplant
14 Increased cancer risk has been comprehensively quantified in kidney transplant recipients female male 95% CI 95% CI Registry data from around the world show consistent increased risk of cancer at most sites Age at cancer diagnosis Webster et al. Am J Transplantation 2007; 7: Relative risk varies by Age Sex Cancer site
15 0 Incident cancer rates after kidney transplantation are similar to people 20+ years older in the gen pop rate per 100, general female population transplant female population 95% confidence intervals general male population transplant male population 95% confidence intervals Age at cancer diagnosis Age at cancer diagnosis Webster et al. Am J Transplantation 2007; 7:
16 proportion with at least 1 non-skin cancer proportion with at least 1 non-skin cancer time in years time in years Cumulative risk of cancer by age transplanted and sex transplanted female general population female <35 years transplanted male general population male transplanted female general population female years transplanted male general population male time in years transplanted female general population female years transplanted male general population male time in years transplanted female general population female 55 years and over transplanted male general population male
17 Impact of cancer: death rate comparisons female Mortality rates by sex male Age transplant with cancer general population with cancer transplant no cancer general population no cancer
18 Impact of cancer on survival within transplant population ANZDATA 15, 183 recipients Mean follow up 9 years Cox model with time dependent covariates
19 Kidney transplant career: (Excl. NMSC, lymphoproliferative, urinary tract and multiple myeloma) Period n observed n expected SIR (95% CI) Chronic kidney disease ( ) Males ( ) Females ( ) During dialysis ( ) Males ( ) Females ( ) After transplantation 1, ( ) Males ( ) Females ( ) Vajdic et al, JAMA 2006
20 Site Results: specific cancers Lip Tongue Mouth Salivary gland Esophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder Pancreas Larynx Lung Melanoma Mesothelioma Kaposi sarcoma Connective tissue Breast Vulva Cervix uteri Corpus uteri Ovary Penis Prostate Testis Eye Brain Thyroid Hodgkin disease Non-Hodgkin lymphoma Leukemia Unspecified All cancers Prior to RRT During dialysis After transplantation SIR
21 What can transplantation tell us about infection and cancer? The context: Transplantation overview and the nature of immunosuppression Epidemiological data on cancer risk How epi relates cancer causality Similarities to other immunosuppressed states Cessation of immunosuppression
22 IARC causality review (up to 2008) Viral agent IARC: Evidence of causality Sufficient Limited Inconclusive Hepatitis B Hepatitis C HTLV-1 HHV8 Liver Liver Adult T-cell lymphoma Kaposi sarcoma Primary effusion lymphoma Epstein-Barr Nasopharynx Salivary gland Hodgkin disease Stomach Non-Hodgkin lymphoma* Lung Human papilloma virus Cervix Anus Vulva Vagina Penis Tongue Tonsil Mouth Oropharynx Nonmelanoma skin Periungal skin Larynx Eye Nasal cavity Colon Lung Breast Ovary Prostate Bladder
23 IARC review Agency of WHO February scientists, 16 countries Reassess evidence of carcinogenicity Epidemiological and molecular mechanistic evidence Weight of evidence for specific cancers Majority vote Evolving Preliminary report Bouvard et al. Lancet Oncology 2009;10: th Monograph
24 IARC classification system Scientific judgement Group 1 Group 2A Group 2B Definition The agent (mixture) is carcinogenic to humans. This category is used when there is sufficient evidence of carcinogenicity in humans. The agent (mixture) is probably carcinogenic to humans. This category is used when there is limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in experimental animals. The agent (mixture) is possibly carcinogenic to humans. This category is used for agents, mixtures and exposure circumstances for which there is limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals. Strong and weak carcinogens... There is no perfect way to classify a continuum of carcinogenic potential. Schiffman et al 2009
25 Cancer after organ transplantation Meta-analysis Cancer risk for all solid organ transplants 97% kidney transplants Grulich et al, Lancet 2007 n= 31,977 Cancer site/type Kaposi s sarcoma Non-Hodgkin s lymphoma Hodgkin disease Liver Stomach Vulva and vagina Penis Anus Oral cavity and pharynx Cervix uteri Lip Non-melanoma skin Eye Oesophagus Larynx Kidney Thyroid Multiple myeloma Bladder Leukemia Melanoma Trachea, bronchus, and lung Colon and rectum Testis Ovary Breast Prostate Brain HHV8 EBV HBV/HCV H. pylori HPV Possible HPV SIR
26 Site Broad-ranging role of viruses Lip Tongue Mouth Salivary gland Esophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder Pancreas Larynx Lung Melanoma Mesothelioma Kaposi sarcoma Connective tissue Breast Vulva Cervix uteri Corpus uteri Ovary Penis Prostate Testis Eye Brain Thyroid Hodgkin disease Non-Hodgkin lymphoma Leukemia Unspecified All cancers Prior to RRT During dialysis After transplantation SIR Sufficient evidence Limited evidence Inconclusive evidence
27 What can transplantation tell us about infection and cancer? The context: Transplantation overview and the nature of immunosuppression Epidemiological data on cancer risk How epi relates cancer causality Similarities to other immunosuppressed states? HIV/ AIDS Cessation of immunosuppression
28 Meta analysis: Incidence of cancers in people with HIV/AIDS and transplant recipients Population-based cancer ascertainment only 7 HIV studies o n>444,000 5 solid organ transplant studies o n~32,000 o 95% kidney Compare patterns of site-specific cancer incidence Grulich et al. Lancet 2007;370:59-67
29 Grulich et al, Lancet 2007 Infection-related cancers Cohort Meta-analysis SIR (95% CI) Number Observed number of studies of cases Heterogeneity p-value EBV related cancers Hodgkin lymphoma HIV / AIDS Transplant ( ) 3.89 ( ) Non-Hodgkin lymphoma HIV / AIDS* Transplant ( ) 8.07 ( ) HHV-8 related cancer Kaposi sarcoma HIV / AIDS* Transplant 3640 ( ) ( ) HBV/HCV related cancer Liver HIV / AIDS 5.22 ( ) Transplant 2.13 ( ) Helicobacter pylori related cancer Stomach HIV / AIDS 1.90 ( ) Transplant 2.04 ( ) SIR Figure 2: Standardised incidence ratios for cancers related to infection with Epstein-Barr virus, human herpesvirus 8, hepatitis B and C virus, and Helicobacter pylori in people with HIV/AIDS and in transplant recipients EBV=Epstein-Barr virus. HBV=hepatitis B virus. HCV=hepatitis C virus. HHV8=human herpesvirus8. *For AIDS-defining cancers, data from cohorts defined by an AIDS diagnosis included only those individuals who did not have that type of cancer at the time of AIDS.
30 HPV-related cancers Cohort Meta-analysis SIR (95% CI) Number Observed number of studies of cases Heterogeneity p-value HPV related cancers Cervix uteri HIV / AIDS* Transplant 5.82 ( ) 2.13 ( ) Vulva and vagina HIV / AIDS Transplant 6.45 ( ) ( ) Penis HIV / AIDS Transplant 4.42 ( ) ( ) Anus HIV / AIDS Transplant ( ) 4.85 ( ) Oral cavity and Pharynx HIV / AIDS Transplant 2.32 ( ) 3.23 ( ) Possibly HPV related cancers Non-melanoma HIV / AIDS Skin Transplant 4.11 ( ) ( ) Lip HIV / AIDS Transplant 2.80 ( ) ( ) Oesophagus HIV / AIDS Transplant 1.62 ( ) 3.05 ( ) Larynx HIV / AIDS Transplant 2.72 ( ) 1.99 ( ) Eye HIV / AIDS Transplant 1.98 ( ) 6.94 ( ) SIR Figure 3: Standardised incidence ratios for cancers related to, or possibly related to, human papillomavirus infection, in people with HIV/AIDS and in transplant recipients HPV=human papillomavirus. *For the AIDS-defining cancer (cervical cancer), data from cohorts defined by an AIDS diagnosis included only those individuals who did not have cervical cancer at the time of AIDS. Excluding lip and nasopharynx. Any measure of non-melanoma skin.
31 Common epithelial cancers Cohort Meta-analysis SIR (95% CI) Number Observed number of studies of cases Heterogeneity p-value Breast HIV / AIDS Transplant 1.03 ( ) 1.15 ( ) Prostate HIV / AIDS Transplant 0.70 ( ) 0.97 ( ) Colon and rectum HIV / AIDS Transplant 0.92 ( ) 1.69 ( ) Ovary HIV / AIDS Transplant 1.63 ( ) 1.55 ( ) Trachea, bronchus, and lung HIV / AIDS Transplant 2.72 ( ) 2.18 ( ) SIR Figure 4: Standardised incidence ratios for common epithelial cancers in people with HIV/AIDS and in transplant recipients Grulich et al, Lancet 2007
32 Other cancers, no known infectious cause Cohort Meta-analysis SIR (95% CI) Number Observed number of studies of cases Heterogeneity p-value Increased in both Kidney HIV / AIDS Transplant 1.50 ( ) 6.78 ( ) Multiple myeloma HIV / AIDS Transplant 2.71 ( ) 3.12 ( ) Leukemia HIV / AIDS Transplant 3.20 ( ) 2.38 ( ) Melanoma HIV / AIDS Transplant 1.24 ( ) 2.34 ( ) Increased in Transplant only Bladder HIV / AIDS Transplant 0.75 ( ) 2.46 ( ) Thyroid HIV / AIDS Transplant 0.84 ( ) 5.91 ( ) Increased in HIV/AIDS only Brain HIV / AIDS Transplant 2.18 ( ) 1.02 ( ) Testis HIV / AIDS Transplant 1.35 ( ) 1.61 ( ) SIR Figure 5: Standardised incidence ratios for other cancers occurring at increased rates in one or both population Grulich et al, Lancet 2007
33 Meta-analysis conclusions Despite marked differences in cancer risk factors, the incidence pattern was very similar for HIV and patient groups A wide range of cancers is associated with immunosuppression Most, but not all, of these cancers are infection related and HPV plays a prominent role
34 Oncogenic virus: KSHV / HHV8 Agent Sufficient evidence of carcinogenesis in humans (Group 1) Limited evidence of carcinogenesis in humans (Group 2A) Established mechanistic events Kaposi sarcoma herpes virus or Human herpes virus-8 Kaposi sarcoma (100%) Primary effusion lymphoma (~97%) Multicentric Castleman s disease (50%) Cell proliferation Inhibition of apoptosis Genomic instability Cell migration No newly identified carcinogenic links Bouvard et al. Lancet 2009;10:
35 Kaposi Sarcoma risk in HIV or transplantation Prior to RRT During dialysis After transplantation Lip Australian Tongue HIV/AIDS registries (n=20,232) linked to Mouth Salivary cancer gland registry Esophagus Stomach Small intestine Colon Rectum Kaposi sarcoma Anus Liver Gallbladder Pancreas Larynx Lung 1000Melanoma Prior to RRT During dialysis After transplantation Mesothelioma Lip Kaposi sarcoma Tongue Connective 100 Mouth tissue Salivary Breast gland Esophagus Vulva 10 Cervix Stomach uteri Small Corpus intestine uteri 1 Ovary Colon Rectum Penis Prostate Anus Pre-HAART Early-HAART Late-HAART Testis Liver Period Gallbladder Eye Pancreas Brain Thyroid Larynx Hodgkin disease Lung Non-Hodgkin lymphoma Melanoma Mesothelioma Leukemia Prior to RRT During dialysis After transplantation Kaposi Unspecified sarcoma Lip Connective All cancers Tongue tissue van Leeuwen Breast Mouth et al. AIDS in press 2009 Vulva gland Cervix Esophagus SIR uteri Corpus Stomach uteri Small intestine Ovary Clifford et al. JNCI 2005;97:425-32
36 Oncogenic virus: EBV Agent Sufficient evidence (Group 1) Limited evidence (Group 2A) Established mechanistic events Epstein-Barr virus Nasopharyngeal carcinoma (98%) Gastric carcinoma (5-10%) Cell proliferation Burkitt s lymphoma (82%) Immune-suppression related non-hodgkin lymphoma (PTLD) (?%) Lymphoepithelioma-like carcinoma (?%) Inhibition of apoptosis Genomic instability Extranodal NK/T-cell lymphoma (nasal type)* (87%) Cell migration Hodgkin lymphoma (46%) Newly identified carcinogenic link known as angiocentric T-cell lymphoma Bouvard et al. Lancet 2009;10: *Previously
37 SIR (95% CI) SIR (95% CI) Lymphoma risk in HIV Key: %EBV +ve tumors in people with HIV. Schulz TF IJC NHL 100 Hodgkin lymphoma % EBV Pre-HAART Early-HAART Late-HAART Period.01 Pre-HAART Early-HAART Late-HAART Period 1000 Diffuse large B-cell lymphoma ~100% EBV 1000 Burkitt lymphoma 30-60% EBV Pre-HAART Early-HAART Late-HAART Period.01 Pre-HAART Early-HAART Late-HAART Period
38 NHL (PTLD: post transplant lymphoproliferative disease) risk in kidney transplant recipients Data linkage, ANZDATA registry (n=8,164) and cancer registry Incidence relative to general population (SIR) 1000 NHL 100 immunosuppression immunosuppression D1 T1 D2+ T2+ Period van Leeuwen et al. Blood 2009;114:630-7
39 NHL risk in kidney transplant recipients Early Late
40 *Adj. for age, sex, EBV status, duration transplantation, receipt of immunosuppressive agents and antibodies; P- values reported for test of homogeneity in nominal covariates Multivariate Results: Early NHL (n=27) n Adjusted IRR (95% CI)* P-value EBV IgG status at transplantation Positive/unknown Negative ( ) <0.001 Receipt of antiproliferative No Yes ( ) Receipt of calcineurin inhibitor No Yes ( ) Receipt of T cell depleting antibody No Yes ( ) 0.031
41 Multivariate Results: Late NHL (n=79) n Adjusted IRR (95% CI)* P-value Age (years) ( ) EBV IgG status at transplantation Positive/unknown Negative ( ) Time since transplantation Receipt of antiproliferative No Yes Receipt of calcineurin inhibitor No Yes Receipt of T cell depleting antibody No Yes ( ) 4.68 ( ) <0.001^ ( ) ( ) ( ) 0.456
42 Oncogenic virus: HPV-16 Agent Sufficient evidence (Group 1) Limited evidence (Group 2A) Established mechanistic events Human papillomavirus type 16 Carcinoma of the: Cervix (100%) Anus (90%) Vagina (40%) Vulva (40%) Penis (40%) Oropharynx (35%) Larynx cancer (3-47%) Immortalisation Genomic instability Inhibition of DNA damage response Anti-apoptotic activity Oral cavity (24%) Tonsil (50%) No newly identified carcinogenic links %s for any HPV infection Bouvard et al. Lancet 2009;10:
43 Other oncogenic HPV types Agent Sufficient evidence (Group 1) Probably carcinogenic (Group 2a) Possibly carcinogenic (Group 2b) HPV 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 Cervical cancer HPV 68 Cervical cancer HPV 26, 53, 66, 67,70, 73, 82 Cervical cancer HPV 30, 34, 69, 85, 97 Cervical cancer HPV 5, 8 Skin cancer in patients with epidermodysplasia verruciformis Newly identified carcinogenic link Bouvard et al. Lancet 2009;10:
44 Is increased cancer risk reversed upon cessation of immunosuppression? Probabilistic data linkage Australia and New Zealand Dialysis and Transplant Registry Dates of change in RRT National Cancer Statistics Clearing House 8,173 patients first transplanted in Australia ,820 returned to dialysis, 668 re-transplanted, 66 received 3 or more transplants SIRs for periods of transplant function and dialysis after transplant failure Incidence rate ratios (IRRs) adjusted for current age, sex and duration of transplantation
45
46
47 Immunosuppression currency and risk The effect of immunosuppression on cancer risk is rapidly reversible for some, but not all, cancer types Risk reversal was mostly, although not exclusively, observed for cancers with a confirmed infectious cause Risk of other cancers, especially those related to ESKD, remains significantly elevated after reduction of immunosuppression This finding offers insight into the role of current functional immunity in cancer prevention and may help inform the management of cancer risk in other immunosuppressed populations
48 SIR (95% CI) Intriguing cancers showing reversibility of risk 1000 Lip cancer 1000 Melanoma D1 T1 D2+ T2+.01 D1 T1 D2+ T2+ Period Period van Leeuwen et al. CEBP 2009;18:561-9 Vajdic et al. CEBP 2009;18:
49 CTS Opelz
50 SIR (95% CI) SIR (95% CI) Cancers showing no change in risk 1000 Colon 1000 Breast D1 T1 D2+ T2+ Period.01 D1 T1 D2+ T2+ Period 1000 Lung cancer 1000 Prostate D1 T1 D2+ T2+ Period.01 D1 T1 D2+ T2+ Period
51 So, final words Transplantation is associated with increased cancer risk across a number of organ sites Most, but not all, are cancers with a known or suspected viral cause Most cancers increase in risk markedly after transplantation Cessation of immunosuppression decreases risk for cancers with known or suspected viral cause Important interaction between common viral infections and the immune system in the etiology of a large number of cancers
52 Claire Vajdic, UNSW Acknowledgements Andrew Grulich, Marina van Leeuwin Jeremy Chapman Colleagues at Sydney Uni Patrick Kelly Custodians and contributors to ANZDATA and other organ transplant registries
53 Questions?
CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster
CHAPTER 10 CANCER REPORT Jeremy Chapman and Angela Webster CANCER REPORT ANZDATA Registry 2004 Report This report summarises the cancer (excluding nonmelanocytic skin cancer) experience of patients treated
More informationCHAPTER 10 CANCER REPORT. Germaine Wong Kirsten Howard Jonathan Craig Stephen McDonald Jeremy Chapman
CHAPTER 10 CANCER REPORT Germaine Wong Kirsten Howard Jonathan Craig Stephen McDonald Jeremy Chapman CANCER REPORT ANZDATA Registry 2006 Report INTRODUCTION RISK OF CANCERS IN KIDNEY DISEASES Notification
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationCONTENTS NOTE TO THE READER... 1
CONTENTS NOTE TO THE READER.... 1 List of Participants... 3 PREAMBLE... 11 A. GENERAL PRINCIPLES AND PROCEDURES...11 1. Background...11 2. Objective and scope.....................................................................................
More informationTaole Mokoena DPhil FRCS Professor of Surgery University of Pretoria Kalafong Hospital 16 TH ANNUAL UP CONTROVERSIES IN SURGERYSYMPOSIUM
Ethical Challenges in Surgical Management of Non-AIDS Defining Malignancies Taole Mokoena DPhil FRCS Professor of Surgery University of Pretoria Kalafong Hospital 16 TH ANNUAL UP CONTROVERSIES IN SURGERYSYMPOSIUM
More informationCancer risk and prevention in persons living with HIV/AIDS (PLWHA) Robert Dubrow, MD, PhD Professor of Epidemiology Yale School of Public Health
Cancer risk and prevention in persons living with HIV/AIDS (PLWHA) Robert Dubrow, MD, PhD Professor of Epidemiology Yale School of Public Health Main collaborators Lesley Park Janet Tate Amy Justice Michael
More informationCancer survival in Shanghai, China,
Cancer survival in Shanghai, China, 1992 1995 Xiang YB, Jin F and Gao YT Abstract The Shanghai cancer registry, established in 1963, is the oldest one in mainland China; cancer registration is entirely
More informationCancer survival in Hong Kong SAR, China,
Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.
More informationAnnual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.
Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and
More informationCancer in Central and South America BOLIVIA
Cancer in Central and South America BOLIVIA This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers
More informationCancer survival in Seoul, Republic of Korea,
Cancer survival in Seoul, Republic of Korea, 1993 1997 Ahn YO and Shin MH Abstract The Seoul cancer registry was established in 1991. Cancer is a notifiable disease, and registration of cases is done by
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationRESEARCH. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study Marina T van Leeuwen, lecturer, epidemiologist, 1,2 Angela C Webster,
More information*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
More information2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill
Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
More informationTruman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence
Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional
More informationChapter 1 MAGNITUDE AND LEADING SITES OF CANCER
Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER Table 1.1 gives the total number of cancers diagnosed at five different hospital based cancer registries (HBCRs), over the period of two years from 1st January
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More informationResearch Article Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Hindawi Publishing Corporation Journal of Cancer Epidemiology Volume 2014, Article ID 437971, 18 pages http://dx.doi.org/10.1155/2014/437971 Research Article Cancer Incidence in Egypt: Results of the National
More informationEpidemiology of SV40-Associated Tumors
Epidemiology of SV40-Associated Tumors Susan G. Fisher, Ph.D. Chief, Division of Epidemiology Community & Preventive Medicine University of Rochester Background Mass polio immunization program in U.S.
More informationCHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
More informationENVIRONMENTAL FACTORS IN VIRUS-ASSOCIATED HUMAN CANCERS
ENVIRONMENTAL FACTORS IN VIRUS-ASSOCIATED HUMAN CANCERS Joint Graduate Seminar Depar tment of Microbiology The Chinese University of Hong Kong PhD Candidate: Zhang Chuqing Super visor: Professor Paul Chan
More informationEpidemiology, Prevention & Early Detection (Cancer Control) The Cancer Control Continuum. Epidemiology
Epidemiology, Prevention & Early Detection (Cancer Control) The Cancer Control Continuum Nancy Thompson, MSN, RN, AOCNS Swedish Cancer Institute Prevention Detection Diagnosis Survivorship Treatment Epidemiology
More informationAmerican Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
More informationCancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
More informationCancer survival in Busan, Republic of Korea,
Cancer survival in Busan, Republic of Korea, 1996 2001 Shin HR, Lee DH, Lee SY, Lee JT, Park HK, Rha SH, Whang IK, Jung KW, Won YJ and Kong HJ Abstract The Busan cancer registry was established in 1996;
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
More informationNational Cancer Statistics in Korea, 2014
National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry Cancer Incidence in Korea, 2014 National Cancer Incidence, 2014 Trends in Cancer Incidence by Sex and Year * Dark colored
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
More informationAging and Cancer in HIV
Aging and Cancer in HIV Ronald Mitsuyasu, MD Professor of Medicine Director, UCLA Center for Clinical AIDS Research and Education Group Chairman, AIDS Malignancy Consortium (AMC) Age distribution of HIV-infected
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
More informationRepublican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus
Republican Research and Practical Center for Radiation Medicine and Human Ecology Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus The contaminated area in the Republic of Belarus consisted
More informationCancer Association of South Africa (CANSA)
Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded
More informationCancer in Ireland with estimates for
Cancer in Ireland 1994-2015 with estimates for 2015-2017: Annual Report of the National Cancer Registry 2017 Page ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More information2016 Cancer Registry Annual Report
2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,
More informationOverview of Gynecologic Cancers in New Jersey
Overview of Gynecologic Cancers in New Jersey New Jersey State Cancer Registry Antoinette M. Stroup, PhD presented at: Gynecologic Cancer Symposium: Striving for a Healthier Tomorrow, Today November 19,
More informationChapter II: Overview
: Overview Chapter II: Overview This chapter provides an overview of the status of cancer in Minnesota, using cases reported to the Minnesota Cancer Surveillance System (MCSS) and deaths reported to the
More informationOverview of 2010 Hong Kong Cancer Statistics
Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research
More informationAll Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
More informationProportion and Number of Cancer Cases and Deaths Attributable to Potentially Modifiable Risk Factors in the United States
CA CANCER J CLIN 2018;68:31 54 Proportion and Number of Cancer Cases and Deaths Attributable to Potentially Modifiable Risk Factors in the United States Farhad Islami, MD, PhD 1 ; Ann Goding Sauer, MSPH
More informationEpidemiology, Prevention & Early Detection
Epidemiology, Prevention & Early Detection Nancy Thompson, MSN, RN, AOCNS Swedish Cancer Institute Epidemiology terminology Cancer statistics Prevention guidelines Screening guidelines Outline Epidemiology
More informationFlorida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
More informationCancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2014 334 Jefferson Avenue, Scranton,
More informationSurvival of End Stage Renal Failure Patients with Cancer
Survival of End Stage Renal Failure Patients with Cancer Angela Webster Centre for Kidney Research, The Children s Hospital at Westmead Department of Renal Medicine, Westmead Hospital, NSW School of Public
More informationSupplementary Online Content
Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.
More informationCancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2018 334 Jefferson Avenue, Scranton,
More informationCancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers
Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2017 334 Jefferson Avenue, Scranton,
More informationHazelinks - Cancer incidence analysis (First data extraction)
Hazelinks - Cancer incidence analysis (First data extraction) Authors Prof Malcolm Sim Ms Christina Dimitriadis Dr Caroline Gao Mr Anthony Del Monaco 1 1 Contents Abbreviations... 3 Executive Summary...
More informationEvaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health Racial and Ethnic Disparities in
More informationOverview of 2009 Hong Kong Cancer Statistics
Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationTrends in Cancer Survival in Scotland
Scottish Cancer Intelligence Unit Trends in Cancer Survival in Scotland - Trends in survival are presented for the half million adult cancer patients diagnosed in Scotland between and. The Results show,
More informationEpidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationLANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013
LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationNational Cancer Patient Experience Survey 2016 Technical Documentation July 2017
National Cancer Patient Experience Survey 2016 Technical Documentation July 2017 1 Contents 1. Introduction 2. Scoring 3. Significance Tests (for national data) 4. Case-mix Adjustment (for local data)
More informationHOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011
HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011 SONGKLANAGARIND HOSPITAL FACULTY OF MEDICINE PRINCE OF SONGKLA UNIVERSITY HATYAI SONGKHLA THAILAND EDITOR PARADEE PRECHAWITTAYAKUL, B.Sc. June, 2013 Songklanagarind
More informationCancer Program Report 2014
Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167
More informationAMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING
AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING ATLAS EDITORS FREDERICK L. GREENE, m.d. Chair, Department of General Surgery Carolinas Medical Center Charlotte, North Carolina CAROLYN C. COMPTON,
More informationCancer in kidney transplant recipients: epidemiology and prevention
BTS 2018, Brighton Cancer in kidney transplant recipients: epidemiology and prevention Adnan Sharif Queen Elizabeth Hospital Birmingham Outline 1. The burden of cancer after kidney transplantation 2. Epidemiology
More informationPrediction of Cancer Incidence and Mortality in Korea, 2013
pissn 1598-2998, eissn 256 Cancer Res Treat. 213;45(1):15-21 Special Article http://dx.doi.org/1.4143/crt.213.45.1.15 Open Access Prediction of Cancer Incidence and Mortality in Korea, 213 Kyu-Won Jung,
More informationHuman Papillomavirus and Related Diseases Report SOUTH AFRICA
Human Papillomavirus and Related Diseases Report SOUTH AFRICA Version posted at www.hpvcentre.net on 10 December 2018 - ii - Copyright and Permissions ICO/IARC Information Centre on HPV and Cancer (HPV
More informationPrediction of Cancer Incidence and Mortality in Korea, 2018
pissn 1598-2998, eissn 256 Cancer Res Treat. 218;5(2):317-323 Special Article https://doi.org/1.4143/crt.218.142 Open Access Prediction of Cancer Incidence and Mortality in Korea, 218 Kyu-Won Jung, MS
More informationHuman Papillomavirus and Related Diseases Report PAPUA NEW GUINEA
Human Papillomavirus and Related Diseases Report PAPUA NEW GUINEA Version posted at www.hpvcentre.net on 10 December 2018 - ii - Copyright and Permissions ICO/IARC Information Centre on HPV and Cancer
More informationKey Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER
The Oncologist Epidemiology and Population Studies: SEER Series Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program MATTHEW
More informationSamuel M. Lesko, MD, MPH Director of Research/Medical Director
Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers Samuel M. Lesko, MD, MPH Director of Research/Medical Director May 11 334 Jefferson Avenue, Scranton, PA 1851-57-941-7984
More information155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
More informationSupplementary Online Content
Supplementary Online Content Chacón MR, Enrico DH, Burton J, Waisberg FD, Videla VM. Incidence of placebo adverse events in randomized clinical trials of targeted and immunotherapy cancer drugs in the
More informationCancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group
Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group Introduction There are more than 200 different types of cancer. It is also referred to as malignancies,
More informationGlobally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute
Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample
More informationCancer in Colorado Incidence, Mortality, and Survival
Cancer in Colorado 1998-2003 Incidence, Mortality, and Survival Jack L. Finch, M.S. Statistical Analyst III Kieu O. Vu, M.S.P.H. Statistical Analyst II 2007 Colorado Central Cancer Registry Randi K. Rycroft,
More informationImpact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption
Impact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption X Dong, Y Ren, R Wilson, and K Zhang NAACCR 6-20-2017 Introduction
More informationCancer in New Brunswick
Cancer in New Brunswick 2002-2006 Message from the New Brunswick Cancer Network (NBCN) Co-CEOs The New Brunswick Cancer Network is pleased to provide the Provincial Cancer Report 2002-2006. This is the
More informationCancer in the North Africa
Cancer in the North Africa Diaa Marzouk Prof Of Public Health Faculty of Medicine, Ain Sams University Presentation Outline Cancer in North Africa Countries according to HDI Cancers in the Eastern Mediterranean
More informationCANCER REGISTRY Annual Report
CANCER REGISTRY Annual Report 2017 Cancer Treatment Centers of America at Southeastern Regional Medical Center Atlanta, Georgia Philadelphia, Pennsylvania Chicago, Illinois Tulsa, Oklahoma Phoenix, Arizona
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1999
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1999 Menzies Centre for Population Health Research University of Tasmania Tasmanian Cancer Registry 17 Liverpool
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2012-2016) AVERAGE NUMBER OF DEATHS PER YEAR (2012-2016) Male Female Both sexes Male Female Both sexes 4,607 4,632 9,240 1 2,238 2,036 4,274
More informationCancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
More informationSKCC Protocol Review Committee New Study Application
Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score
More informationCANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012
CANCER IN NSW ABORIGINAL PEOPLES Incidence, mortality and survival September 2012 CANCER IN NSW ABORIGINAL PEOPLES Contents Tables 1 Figures 2 Message from the Chief Cancer Officer 4 Executive summary
More informationSTUDY. Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin
Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin Kari Hemminki, MD, PhD; Chuanhui Dong, MD, PhD STUDY Objectives: To compare cancer risks after in situ and invasive squamous
More informationHuman Papillomavirus and Related Diseases Report LESOTHO
Human Papillomavirus and Related Diseases Report LESOTHO Version posted at www.hpvcentre.net on 10 December 2018 - ii - Copyright and Permissions ICO/IARC Information Centre on HPV and Cancer (HPV Information
More informationDo Viruses Play a Role in Childhood Leukaemia?
CHILDREN with LEUKAEMIA, 6 September 2004 Do Viruses Play a Role in Childhood Leukaemia? Robin A. Weiss Natural Bioweapons of Mass Destruction A Richter Scale of Viruses and Global Mortality HIV HBV +
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2011-2015) AVERAGE NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 4,557 4,516 9,073 1 2,196 1,984 4,180
More informationConstruction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts
Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts Chris Johnson, Cancer Data Registry of Idaho NAACCR 2016 Annual Conference June 14, 2016 Concurrent
More informationNov FromAtoZCodesMatter
Nov 2017 FromAtoZCodesMatter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA The implementation of ICD-10 brought tens of thousands of new codes. Ranging from A to Z, they portray
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1994-213: Annual Report of the National Cancer Registry 215 Page 3 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised rate (European standard
More informationCancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer
Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more
More informationHuman Papillomavirus and Related Diseases Report MEXICO
Human Papillomavirus and Related Diseases Report MEXICO Version posted at www.hpvcentre.net on 10 December 2018 - ii - Copyright and Permissions ICO/IARC Information Centre on HPV and Cancer (HPV Information
More informationHuman Papillomavirus and Related Diseases Report SRI LANKA
Human Papillomavirus and Related Diseases Report SRI LANKA Version posted at www.hpvcentre.net on 10 December 2018 - ii - Copyright and Permissions ICO/IARC Information Centre on HPV and Cancer (HPV Information
More informationHUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014
HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014 COMMISSION ON CANCER STANDARD 1.12 Hunt Cancer Institute Mission Statement To be first in the South Bay/Peninsula communities in the provision of quality
More informationAN EMPIRICAL EVALUATION OF PERIOD SURVIVAL ANALYSIS USING DATA FROM THE CANADIAN CANCER REGISTRY. Larry F. Ellison MSc, Statistics Canada
AN EMPIRICAL EVALUATION OF PERIOD SURVIVAL ANALYSIS USING DATA FROM THE CANADIAN CANCER REGISTRY Larry F. Ellison MSc, Statistics Canada Introduction Long-term survival rates are important outcome measures
More informationCancer Treatment Centers of America ATLANTA CANCER REGISTRY. Annual Report
Cancer Treatment Centers of America ATLANTA CANCER REGISTRY Annual Report CANCER COMMITTEE Chairman s Report On behalf of the Cancer Committee a multidisciplinary team of boardcertified physicians and
More informationHuman Papillomavirus and Related Diseases Report MONGOLIA
Human Papillomavirus and Related Diseases Report MONGOLIA Version posted at www.hpvcentre.net on 10 December 2018 - ii - Copyright and Permissions ICO/IARC Information Centre on HPV and Cancer (HPV Information
More informationHuman papillomavirus and vaccination for cervical cancer
Human papillomavirus and vaccination for cervical cancer Dorothy Machalek Department of Microbiology and Infectious Diseases Royal Women s Hospital, Melbourne, Australia VIRUSES AND CANCER Responsible
More information